• bitcoinBitcoin(BTC)$86,676.007.10%
  • ethereumEthereum(ETH)$2,771.945.54%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$804.845.16%
  • rippleXRP(XRP)$1.5510.23%
  • usd-coinUSDC(USDC)$1.000.02%
  • solanaSolana(SOL)$119.418.61%
  • tronTRON(TRX)$0.3442150.46%
  • zcashZcash(ZEC)$1,458.89-1.72%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.010.00%
  • HyperliquidHyperliquid(HYPE)$93.360.70%
  • dogecoinDogecoin(DOGE)$0.09956814.28%
  • moneroMonero(XMR)$596.545.86%
  • whitebitWhiteBIT Coin(WBT)$87.195.52%
  • RainRain(RAIN)$0.013975-0.85%
  • chainlinkChainlink(LINK)$13.165.69%
  • USDSUSDS(USDS)$1.000.01%
  • cardanoCardano(ADA)$0.2450948.05%
  • leo-tokenLEO Token(LEO)$8.940.17%
  • stellarStellar(XLM)$0.21700911.00%
  • uniswapUniswap(UNI)$8.810.40%
  • bitcoin-cashBitcoin Cash(BCH)$268.747.48%
  • nearNEAR Protocol(NEAR)$4.11-1.92%
  • avalanche-2Avalanche(AVAX)$11.310.11%
  • Ethena USDeEthena USDe(USDE)$1.000.00%
  • litecoinLitecoin(LTC)$62.226.17%
  • daiDai(DAI)$1.00-0.03%
  • CantonCanton(CC)$0.1159957.72%
  • USD1USD1(USD1)$1.000.00%
  • suiSui(SUI)$1.0214.82%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.455.35%
  • hedera-hashgraphHedera(HBAR)$0.0920706.44%
  • shiba-inuShiba Inu(SHIB)$0.0000068.98%
  • BittensorBittensor(TAO)$308.1418.12%
  • MemeCoreMemeCore(M)$1.47-0.33%
  • crypto-com-chainCronos(CRO)$0.06560410.34%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • paypal-usdPayPal USD(PYUSD)$1.000.02%
  • tether-goldTether Gold(XAUT)$4,340.14-0.69%
  • okbOKB(OKB)$123.294.55%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • BitwayBitway(BTW)$0.8715.34%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.14-0.12%
  • aaveAave(AAVE)$144.285.38%
  • OndoOndo(ONDO)$0.4515665.85%
  • mantleMantle(MNT)$0.657.42%
  • EthenaEthena(ENA)$0.208970-3.86%
  • polkadotPolkadot(DOT)$1.193.25%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

SYNCOGEN: A Machine Learning Framework for Synthesizable 3D Molecular Generation Through Joint Graph and Coordinate Modeling

July 24, 2025
in AI & Technology
Reading Time: 10 mins read
A A
SYNCOGEN: A Machine Learning Framework for Synthesizable 3D Molecular Generation Through Joint Graph and Coordinate Modeling
ShareShareShareShareShare

Introduction: The Challenge of Synthesizable Molecule Generation

In modern drug discovery, generative molecular design models have greatly expanded the chemical space available to researchers, enabling rapid exploration of new compounds. Yet, a major challenge remains: many AI-generated molecules are difficult or impossible to synthesize in the laboratory, limiting their practical value in pharmaceutical and chemical development.

While template-based methods—such as synthesis trees constructed from reaction templates—help address synthetic accessibility, these approaches only capture 2D molecular graphs, lacking the rich 3D structural information that determines a molecule’s behaviour in biological systems.

YOU MAY ALSO LIKE

AWS Strands Agents Team Releases Strands Harness: An Open-Source Agent Harness With 28% Lower Token Cost at Comparable Accuracy

Bungie Leaders Now Say The Studio’s ‘Not Done With Destiny’

Bridging 3D Structure and Synthesis: The Need for a Unified Framework

Recent advances in 3D generative models can directly generate atomic coordinates, allowing for geometry-based design and improved property prediction. However, most methods do not systematically integrate synthetic feasibility constraints: the resulting molecules may possess desired shapes or properties, but there is no guarantee they can be assembled from existing building blocks using known reactions.

Synthetic accessibility is crucial for successful drug discovery and materials design, prompting the need for solutions that simultaneously ensure both realistic 3D geometry and direct synthetic routes.

SYNCOGEN: A Novel Framework for Synthesizable 3D Molecule Design

Researchers from the University of Toronto, University of Cambridge, McGill University, and others have proposed SYNCOGEN (Synthesizable Co-Generation) that addresses this gap with a pioneering approach that jointly models both reaction pathways and atomic coordinates during molecule generation. This unified framework enables the generation of 3D molecular structures along with tractable synthetic routes, ensuring that every proposed molecule is not only physically meaningful but also practically synthesizable.

Key Innovations of SYNCOGEN

  • Multimodal Generation: By blending masked graph diffusion (for reaction graphs) with flow matching (for atomic coordinates), SYNCOGEN samples from the joint distribution of building blocks, chemical reactions, and 3D structures.
  • Comprehensive Input Representation: Each molecule is represented as a triple (X, E, C), where:
    • X encodes building block identity,
    • E encodes reaction types and specific connection centers,
    • C contains all atomic coordinates.
  • Simultaneous Training: Both graph and coordinate modalities are modeled together, using losses that combine cross-entropy for graphs, masked mean squared error for coordinates, and pairwise distance penalties to ensure geometric realism.

The SYNSPACE Dataset: Enabling Large-Scale, Synthesizability-Aware Training

To train SYNCOGEN, researchers created SYNSPACE, a dataset featuring over 600,000 synthesizable molecules, each constructed from 93 commercial building blocks and 19 robust reaction templates. Every molecule in SYNSPACE is annotated with multiple energy-minimized 3D conformations (over 3.3 million structures total), providing a diverse and reliable training resource that closely mirrors realistic chemical synthesis.

Dataset Construction Workflow

  • Molecules are systematically built by iterative reaction assembly, starting from an initial building block and choosing compatible reaction centers and partners for successive coupling steps.
  • For each resulting molecular graph, multiple low-energy conformers are generated and optimized using computational chemistry methods, ensuring each structure is both chemically plausible and energetically favourable.

Model Architecture and Training

SYNCOGEN leverages a modified SEMLAFLOW backbone, an SE(3)-equivariant neural network originally designed for 3D molecular generation. The architecture includes:

  • Specialized input and output heads to translate between building block-level graphs and atom-level features.
  • Loss functions and noising schemes that carefully balance graph accuracy and 3D structural fidelity, including visibility-aware coordinate handling to support variable atom counts and masking.
  • Training innovations such as edge count limits, compatibility masking, and self-conditioning to maintain chemistry-valid molecule generation.

Performance: State-of-the-Art Results in Synthesizable Molecule Generation

Benchmarking

SYNCOGEN achieves state-of-the-art performance on unconditional 3D molecule generation tasks, outperforming leading all-atom and graph-based generative frameworks. Notable improvements include:

  • High chemical validity: More than 96% of generated molecules are chemically valid.
  • Superior synthetic accessibility: Retrosynthesis software (AiZynthFinder, Syntheseus) solve rates of up to 72%, far surpassing most competing methods.
  • Excellent geometric and energetic realism: Generated conformers closely match the bond length, angle, and dihedral distributions of experimental datasets, with low non-bonded interaction energies.
  • Practical utility: SYNCOGEN enables direct generation of synthetic routes alongside 3D coordinates, uniquely bridging computational chemistry and experimental synthesis.

Fragment Linking and Drug Design

SYNCOGEN also demonstrates competitive performance in molecular inpainting for fragment linking, a crucial drug design task. It can generate easily synthesizable analogs of complex drugs, producing candidates with favorable docking scores and retrosynthetic tractability—a feat not matched by conventional 3D generative models.

Future Directions and Applications

SYNCOGEN marks a foundational advance for synthesizability-aware molecular generation, with potential extensions including:

  • Property-conditioned generation: Directly optimize for desired physicochemical or biological properties.
  • Protein pocket conditioning: Generate ligands customized for specific protein binding sites.
  • Expanding reaction space: Incorporate more diverse building blocks and reaction templates to widen accessible chemical space.
  • Automated synthesis robotics: Link generative models with laboratory automation for closed-loop drug and materials discovery.

Conclusion: A Step Toward Realizable Computational Molecular Design

SYNCOGEN sets a new benchmark for joint 3D and reaction-aware molecule generation, enabling researchers and pharmaceutical scientists to design molecules that are both structurally meaningful and experimentally feasible. By uniting generative models with strict synthetic constraints, SYNCOGEN brings computational design much closer to laboratory realization, unlocking new opportunities in drug discovery, materials science, and beyond.


FAQ 1: What is SYNCOGEN and how does it improve synthesizable 3D molecule generation?
SYNCOGEN is an advanced generative modeling framework that simultaneously generates both the 3D structures and the synthetic reaction pathways for small molecules. By jointly modeling reaction graphs and atomic coordinates, SYNCOGEN ensures that generated molecules are not only physically realistic but also easily synthesizable in real-world laboratory settings. This dual approach uniquely enables practical molecule design for drug discovery, bridging a critical gap left by earlier models that focused only on 2D structures or neglect synthetic accessibility.

FAQ 2: How is SYNCOGEN trained to guarantee synthetic accessibility and 3D accuracy?
SYNCOGEN is trained using the SYNSPACE dataset, which includes over 600,000 synthesizable molecules constructed from a fixed set of reliable building blocks and reaction templates, each paired with multiple energy-minimized 3D conformers. The model utilizes masked graph diffusion for the reaction graph and flow matching for atomic coordinates, combining graph cross-entropy, coordinate mean squared error, and pairwise distance penalties during training to enforce both chemical validity and geometric realism. Training-time constraints, such as edge count limits and compatibility masking, further ensure the generation of practical, chemistry-valid molecules.

FAQ 3: What are the main applications and future directions for SYNCOGEN in chemical and pharmaceutical research?
SYNCOGEN sets a new standard for synthesizability-aware 3D molecule generation, enabling direct suggestion of synthetic routes alongside 3D structures—key for drug design, fragment linking, and automated synthesis platforms. Future applications include conditioning generation on specific properties or protein binding pockets, expanding the library of applicable reactions and building blocks, and integrating with laboratory robotics for fully automated molecule synthesis and screening.


Check out the Paper here. All credit for this research goes to the researchers of this project.

Meet the AI Dev Newsletter read by 40k+ Devs and Researchers from NVIDIA, OpenAI, DeepMind, Meta, Microsoft, JP Morgan Chase, Amgen, Aflac, Wells Fargo and 100s more [SUBSCRIBE NOW]


Sajjad Ansari is a final year undergraduate from IIT Kharagpur. As a Tech enthusiast, he delves into the practical applications of AI with a focus on understanding the impact of AI technologies and their real-world implications. He aims to articulate complex AI concepts in a clear and accessible manner.

Credit: Source link

ShareTweetSendSharePin

Related Posts

AWS Strands Agents Team Releases Strands Harness: An Open-Source Agent Harness With 28% Lower Token Cost at Comparable Accuracy
AI & Technology

AWS Strands Agents Team Releases Strands Harness: An Open-Source Agent Harness With 28% Lower Token Cost at Comparable Accuracy

September 21, 2026
Bungie Leaders Now Say The Studio’s ‘Not Done With Destiny’
AI & Technology

Bungie Leaders Now Say The Studio’s ‘Not Done With Destiny’

September 21, 2026
Here’s Why Apple’s Mac Studio Has Become So Expensive
AI & Technology

Here’s Why Apple’s Mac Studio Has Become So Expensive

September 21, 2026
Tesla Will Soon Roll Out FSD Supervised In The Czech Republic
AI & Technology

Tesla Will Soon Roll Out FSD Supervised In The Czech Republic

September 21, 2026
Next Post
Lead investigator into Biden autopen signed his own letters with a digital signature

Lead investigator into Biden autopen signed his own letters with a digital signature

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Aaron Judge lands on IL with calf strain in Yankees nightmare – New York Post

Aaron Judge lands on IL with calf strain in Yankees nightmare – New York Post

September 18, 2026
OpenAI, Anthropic Safety Talks Stir Startup Concerns

OpenAI, Anthropic Safety Talks Stir Startup Concerns

September 20, 2026
Viasat: Equatys Makes The Story Better, But The Stock Is Still A Hold (NASDAQ:VSAT)

Viasat: Equatys Makes The Story Better, But The Stock Is Still A Hold (NASDAQ:VSAT)

September 16, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!